US Stock MarketDetailed Quotes

JSPR Jasper Therapeutics

Watchlist
  • 21.590
  • -1.620-6.98%
Close Apr 19 16:00 ET
  • 21.590
  • 0.0000.00%
Post 16:00 ET
325.23MMarket Cap-3493P/E (TTM)

About Jasper Therapeutics Company

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.

Company Profile

SymbolJSPR
Company NameJasper Therapeutics
Listing DateJan 10, 2020
Founded2018
CEOMr. Ronald A. Martell
MarketNASDAQ
Employees45
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2200 Bridge Parkway,Suite 102
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94065
Phone1-650-549-1400

Company Executives

  • Name
  • Position
  • Salary
  • Ronald A. Martell
  • Director, President and Chief Executive Officer
  • 5.64M
  • Jeet Mahal
  • Chief Operating Officer
  • 1.11M
  • Herbert C. Cross
  • Corporate Secretary, Acting Chief Financial Officer and Principal Accounting Officer
  • --
  • Thomas G. Wiggans
  • Chairman of the Board
  • --
  • Dr. Scott C. Brun, M.D.
  • Director
  • --
  • Dr. Judith Shizuru, M.D.,PhD
  • Director
  • 513.13K
  • Christian W. Nolet
  • Independent Director
  • 285.81K
  • Dr. Anna French, D.Phil.
  • Independent Director
  • 284.07K
  • Vishal Kapoor
  • Independent Director
  • --
  • Kurt von Eer, C.F.A.
  • Independent Director
  • 284.23K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg